Sex-specific differences in natriuretic peptide and nitric oxide synthase expression in ANP gene-disrupted mice

Molecular and Cellular Biochemistry

Volumn 374, Issue 1-2, 2013, Pages 125-135

  Wong, Philip G ^a   Armstrong, David W J ^a   Tse, M Yat ^a   Brander, Emily P A ^a   Pang, Stephen C ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Atrial natriuretic peptide; Estrous cycle; Heart; Mouse; Nitric oxide synthase

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GUANYLATE CYCLASE; GUANYLATE CYCLASE ALPHA 1; GUANYLATE CYCLASE BETA 1; INDUCIBLE NITRIC OXIDE SYNTHASE; NATRIURETIC FACTOR; NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; ATRIAL NATRIURETIC PEPTIDE GENE; CARDIOVASCULAR DISEASE; ENZYME IMMUNOASSAY; ESTRUS; ESTRUS CYCLE; FEMALE; GENE; GENE CONTROL; GENE DISRUPTION; GENE EXPRESSION; GENOTYPE; HEART LEFT VENTRICLE; HEART PROTECTION; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SEX DIFFERENCE;

ANIMALS; ATRIAL NATRIURETIC FACTOR; CARDIOMEGALY; CARDIOVASCULAR DISEASES; CYCLIC GMP; FEMALE; GENE EXPRESSION; HEART VENTRICLES; MALE; MICE; MICE, KNOCKOUT; NATRIURETIC PEPTIDES; NITRIC OXIDE SYNTHASE; RNA, MESSENGER; SEX CHARACTERISTICS;

MUS;

EID: 84871957275     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-012-1511-8     Document Type: Article

References (53)

1. Johannes J, Bairey Merz CN (2011) Is cardiovascular disease in women inevitable? Cardiol Rev 19:76-80
2. Murphy E, Lagranha C, Deschamps A, Kohr M, Nguyen T, Wong R et al (2011) Mechanism of cardioprotection: what can we learn from females? Pediatr Cardiol 32:354-359
3. Mendelsohn ME (2005) Molecular and cellular basis of cardiovascular gender differences. Science 308:1583-1587
4. Hayward CS, Kelly RP, Collins P (2000) The roles of gender, the menopause and hormone replacement on cardiovascular function. Cardiovasc Res 46:28-49
5. Prentice RL (2005) Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial. Am J Epidemiol 162:404-414
6. Harman SM (2006) Estrogen replacement in menopausal women: recent and current prospective studies, the WHI and the KEEPS. Gend Med 3:254-269
7. Giardina EG (2000) Heart disease in women. Int J Fertil Womens Med 45:350-357
8. Lorell BH, Carabello BA (2000) Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation 102:470-479
9. Rajabi M, Kassiotis C, Razeghi P, Taegtmeyer H (2007) Return to the fetal gene program protects the stressed heart: a strong hypothesis. Heart Fail Rev 12:331-343
10. Heineke J, Molkentin JD (2006) Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 7:589-600
11. Tremblay J, Gerzer R, Vinay P, Pang SC, Béliveau R, Hamet P (1985) The increase of cGMP by atrial natriuretic factor correlates with the distribution of particulate guanylate cyclase. FEBS Lett 181:17-22
12. Hamet P, Tremblay J, Pang SC, Garcia R, Thibault G, Gutkowska J et al (1984) Effect of native and synthetic atrial natriuretic factor on cyclic GMP. Biochem Biophys Res Commun 123:515-527
13. Song DL, Kohse KP, Murad F (1988) Brain natriuretic factor. Augmentation of cellular cyclic GMP, activation of particulate guanylate cyclase and receptor binding. FEBS Lett 232:125-129
14. Waldman SAS, Rapoport RMR, Murad FF (1984) Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissues. J Biol Chem 259:14332-14334
15. van den Akker F, Zhang X, Miyagi M, Huo X, Misono KS, Yee VC (2000) Structure of the dimerized hormone-binding domain of a guanylyl-cyclase-coupled receptor. Nature 406:101-104
16. Maack T, Suzuki M, Almeida FA, Nussenzveig D, Scarborough RM, McEnroe GA et al (1987) Physiological role of silent receptors of atrial natriuretic factor. Science 238:675-678
17. Schmidt HH, Pollock JS, Nakane M, Gorsky LD, Förstermann U, Murad F (1991) Purification of a soluble isoform of guanylyl cyclase-activating-factor synthase. Proc Natl Acad Sci USA 88:365-369
18. Balligand JL, Kelly RA, Marsden PA, Smith TW, Michel T (1993) Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci USA 90:347-351
19. Balligand JL, Cannon PJ (1997) Nitric oxide synthases and cardiac muscle. Autocrine and paracrine influences. Arterioscler Thromb Vasc Biol 17:1846-1858
20. McDonald LJ, Murad F (1996) Nitric oxide and cyclic GMP signaling. Proc Soc Exp Biol Med 211:1-6
21. Kato T, Muraski J, Chen Y, Tsujita Y, Wall J, Glembotski CC et al (2005) Atrial natriuretic peptide promotes cardiomyocyte survival by cGMP-dependent nuclear accumulation of zyxin and Akt. J Clin Invest 115:2716-2730
22. Matsui T, Rosenweig A (2005) Convergent signal transduction pathways controlling cardiomyocyte survival and function: the role of PI 3-kinase and Akt. J Mol Cell Cardiol 38:63-71
23. Manoury B, Montiel V, Balligand JL (2012) Nitric oxide synthase in post-ischaemic remodelling: new pathways and mechanisms. Cardiovasc Res 94:304-315
24. John SW, Krege JH, Oliver PM, Hagaman JR, Hodgin JB, Pang SC et al (1995) Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 267:679-681
25. Angelis E, Tse MY, Pang SC (2005) Interactions between atrial natriuretic peptide and the renin-angiotensin system during salt-sensitivity exhibited by the proANP gene-disrupted mouse. Mol Cell Biochem 276:121-131
26. Tse MY, Watson JD, Sarda IR, Flynn TG, Pang SC (2001) Expression of B-type natriuretic peptide in atrial natriuretic peptide gene disrupted mice. Mol Cell Biochem 219:99-105
27. Baylis F (2010) Pregnant women deserve better. Nature 465:689-690
28. Kim AM, Tingen CM, Woodruff TK (2010) Sex bias in trials and treatment must end. Nature 465:688-689
29. Zucker I, Beery AK (2010) Males still dominate animal studies. Nature 465:690
30. McBride SM, Flynn FW, Ren J (2005) Cardiovascular alteration and treatment of hypertension: do men and women differ? Endocrine 28:199-207
31. Leinwand LA (2003) Sex is a potent modifier of the cardiovascular system. J Clin Invest 112:302-307
32. Gensini GF, Micheli S, Prisco D, Abbate R (1996) Menopause and risk of cardiovascular disease. Thromb Res 84:1-19
33. Jankowski M (2005) Pregnancy alters nitric oxide synthase and natriuretic peptide systems in the rat left ventricle. J Endocrinol 184:209-217
34. Madhani M, Scotland RS, MacAllister RJ, Hobbs AJ (2003) Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling. Br J Pharmacol 139:1289-1296
35. Kotlo KU, Rasenick MM, Danziger RS (2009) Evidence for cross-talk between atrial natriuretic peptide and nitric oxide receptors. Mol Cell Biochem 338:183-189
36. Wang TJ, Larson MG, Levy D, Leip EP, Benjamin EJ, Wilson PWF et al (2002) Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol 90:254-258
37. Raizada V, Thakore K, Luo W, McGuire PG (2001) Cardiac chamber-specific alterations of ANP and BNP expression with advancing age and with systemic hypertension. Mol Cell Biochem 216:137-140
38. Gyurko R, Kuhlencordt P, Fishman MC, Huang PL (2000) Modulation of mouse cardiac function in vivo by eNOS and ANP. Am J Physiol Heart Circ Physiol 278:H971-H981
39. Li W, Mital S, Ojaimi C, Csiszar A, Kaley G, Hintze TH (2004) Premature death and age-related cardiac dysfunction in male eNOS-knockout mice. J Mol Cell Cardiol 37:671-680
40. Jankowski M, Reis AM, Mukaddam-Daher S, Dam TV, Farookhi R, Gutkowska J (1997) C-type natriuretic peptide and the guanylyl cyclase receptors in the rat ovary are modulated by the estrous cycle. Biol Reprod 56:59-66
41. Reis AM, Jankowski M, Mukaddam-Daher S, Tremblay J, Dam TV, Gutkowska J (1997) Regulation of the natriuretic peptide system in rat uterus during the estrous cycle. J Endocrinol 153:345-355
42. Noubani AA, Farookhi RR, Gutkowska JJ (2000) B-type natriuretic peptide receptor expression and activity are hormonally regulated in rat ovarian cells. Endocrinology 141:551-559
43. Puri V, Cui L, Liverman CS, Roby KF, Klein RM, Welch KMA et al (2005) Ovarian steroids regulate neuropeptides in the trigeminal ganglion. Neuropeptides 39:409-417
44. Sica M, Martini M, Viglietti-Panzica C, Panzica G (2009) Estrous cycle influences the expression of neuronal nitric oxide synthase in the hypothalamus and limbic system of female mice. BMC Neurosci 10:78
45. Kleinert H, Wallerath T, Euchenhofer C, Ihrig-Biedert I, Li H, Förstermann U (1998) Estrogens increase transcription of the human endothelial NO synthase gene: analysis of the transcription factors involved. Hypertension 31:582-588
46. Nuedling S, Kahlert S, Loebbert K, Doevendans PA, Meyer R, Vetter H et al (1999) 17 Beta-estradiol stimulates expression of endothelial and inducible NO synthase in rat myocardium in vitro and in vivo. Cardiovasc Res 43:666-674
47. Patten RD, Pourati I, Aronovitz MJ, Alsheikh-Ali A, Eder S, Force T et al (2008) 17 Beta-estradiol differentially affects left ventricular and cardiomyocyte hypertrophy following myocardial infarction and pressure overload. J Card Fail 14:245-253
48. Bhuiyan MS, Shioda N, Fukunaga K (2007) Ovariectomy augments pressure overload-induced hypertrophy associated with changes in Akt and nitric oxide synthase signaling pathways in female rats. Am J Physiol Endocrinol Metab 293:E1606-E1614
49. Sangaralingham SJ, Tse MY, Pang SC (2007) Estrogen delays the progression of salt-induced cardiac hypertrophy by influencing the renin-angiotensin system in heterozygous proANP gene-disrupted mice. Mol Cell Biochem 306:221-230
50. Sangaralingham SJ, Tse MY, Pang SC (2007) Estrogen protects against the development of salt-induced cardiac hypertrophy in heterozygous proANP gene-disrupted mice. J Endocrinol 194:143-152
51. Fischmeister R, Castro LRV, Abi-Gerges A, Rochais F, Jurevicius J, Leroy J et al (2006) Compartmentation of cyclic nucleotide signaling in the heart: the role of cyclic nucleotide phosphodiesterases. Circ Res 99:816-828
52. Pimenta E (2012) Hypertension in women. Hypertens Res 35:148-152
53. Engberding N, Wenger NK (2012) Management of hypertension in women. Hypertens Res 35:251-260